Quanticate Appoints Praveen Arockiaraj as VP and Head of Clinical Data Management
Quanticate appoints Praveen Arockiaraj as VP and Head of Clinical Data Management, bringing over 22 years of clinical research and data management experience.
Learn more
Quanticate announces strategic partnership with PhaseV
Quanticate is pleased to announce its strategic partnership with PhaseV, a pioneer in software and machine learning (ML) for adaptive clinical trial optimization on a new technology-based service.
Learn more
Quanticate Strengthens Leadership Team with New Appointment
Quanticate, a global biometric clinical research organization (CRO), has announced the appointment of Richard Morton as Head of Statistics.
Learn more
Learn more
Quanticate announces strategic partnership with KPS Life.
Quanticate is pleased to announce its strategic partnership with KPS Life, a US-based provider of Functional Service Provision solutions focused on clinical operations and clinical monitoring oversight.
Learn more
Quanticate is finalist at the Citeline Awards 2023
Quanticate is pleased to announce that we have been selected as a finalist for the Excellence in Use of Real-World Evidence category in the Citeline Awards 2023.
Learn more
Quanticate is Bronze Sponsor at this year's 31st Pharmacovigilance Conference
Quanticate is Bronze Sponsor at this year's 31st Pharmacovigilance Conference, 1st - 2nd February.
Learn more
Quanticate announces plans to accelerate growth in North America
Quanticate, a global data-focused clinical research organization (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
Learn more
Quanticate Launches a New Logo
We are proud to announce the launch of the new company logo as part of Quanticate's ongoing evolution.
Learn more
Quanticate supports Rare Disease Day 2022
28 February is Rare Disease Day, and we proudly support this globally-coordinated movement working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.
Learn more
Quanticate supports DETERMINE study by Cancer Research UK
Quanticate are delighted to have the opportunity to support Cancer Research UK with their new study DETERMINE.
Learn more
Quanticate Expands Leadership Team with new EVP of Business Development
Quanticate Expands Leadership Team with new EVP of Business Development
Learn more
.png?width=110&name=ACDM_Corporate_Member_Badge_135%20(3).png){kind=icon}
.png?width=140&name=cdisc_gold_partner_80h%20(2).png)
